Barinthus Biotherapeutics plc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2020 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Barinthus Biotherapeutics plc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2020 to Q4 2023.
  • Barinthus Biotherapeutics plc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $25.1M, a 82.8% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $25.1M +$11.4M +82.8% Dec 31, 2023 10-K 2024-03-20
Q4 2022 $13.7M +$207K +1.53% Dec 31, 2022 10-K 2024-03-20
Q4 2021 $13.5M +$6.22M +85.4% Dec 31, 2021 10-K 2024-03-20
Q4 2020 $7.28M Dec 31, 2020 10-K 2022-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.